STIMULATE-ICP (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways)

  • Funded by Department of Health and Social Care / National Institute for Health and Care Research (DHSC-NIHR)
  • Total publications:30 publications

Grant number: COV-LT2-0043

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2021
    2025
  • Known Financial Commitments (USD)

    $9,752,888.6
  • Funder

    Department of Health and Social Care / National Institute for Health and Care Research (DHSC-NIHR)
  • Principal Investigator

    N/A

  • Research Location

    United Kingdom
  • Lead Research Institution

    University College London Hospitals NHS Foundation Trust
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Disease pathogenesis

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)

  • Vulnerable Population

    Vulnerable populations unspecified

  • Occupations of Interest

    Unspecified

Abstract

Long Covid is affecting over a million people in the UK. The wide-ranging symptoms are disabling, and need joined-up care from specialists, hospitals and community services. Over 80 long COVID clinics have been established but we need to better understand, diagnose and treat the disease. We will design and test the best ways to care for people with long COVID. We will bring together six regions: Derby, Exeter, Hull, Leicester, Liverpool, and London, and include the Royal College of General Practitioners policy team, health professionals and academics. Four patient organisations have helped to develop this proposal. They will be involved across the project from design to dissemination. To improve recovery, we will work out what long COVID is, how to diagnose it and how to manage it. The data and findings will be easily accessible to aid further research and service improvement. We will interview patients and health professionals and analyse data from NHS records. This will inform our understanding of patterns of long COVID and the outcomes of current clinical practice. Usual care involves basic investigations such as blood tests and self-management of rehabilitation using a website https://www.yourcovidrecovery.nhs.uk/ . We will recruit over 4,500 patients in the largest long-COVID trial to-date. We will compare a new pathway including community-based, comprehensive MRI scan (CoverscanTM) and enhanced rehabilitation (Living with COVID RecoveryTM) with usual care. We will also test different drugs, including aspirin, colchicine and loratadine/famotidine. We will measure effects of three months treatment by symptoms, mental health, return to work and other important outcomes. With patients, we will co-develop means to improve patient access to the right care at the right time in the right place, including health professional training. We will consider the aspects of long COVID care which might improve care for patients with multimorbidity and long-term conditions.

Publicationslinked via Europe PMC

Healthcare utilisation of 282,080 individuals with long COVID over two years: a multiple matched control, longitudinal cohort analysis.

Integrated care policy recommendations for complex multisystem long term conditions and long COVID.

What is current care for people with Long COVID in England? A qualitative interview study.

Accessing care for Long Covid from the perspectives of patients and healthcare practitioners: A qualitative study.

Disparities by Social Determinants of Health: Links Between Long COVID and Cardiovascular Disease.

Barriers to healthcare access and experiences of stigma: Findings from a coproduced Long Covid case-finding study.

Pathways to care for Long COVID and for long-term conditions from patients' and clinicians' perspective.

Sociodemographic and health-related differences in undiagnosed hypertension in the health survey for England 2015-2019: a cross-sectional cohort study.

Cardiac abnormalities in Long COVID 1-year post-SARS-CoV-2 infection.